Most major Canadian insurers (Manulife, Canada Life, Blue Cross, GreenShield) now have Wegovy on their prior authorization lists, meaning your doctor must submit documentation proving the medication is medically necessary
When expanding trial eligibility criteria to reflect broader patient populations typically encountered in clinical practice, we identified 453,201 individuals initiating semaglutide or sitagliptin (expanding SUSTAIN-6 eligibility) and 136,089 initiating tirzepatide or dulaglutide (expanding SURPASS-CVOT eligibility)
Dispose of properly in port or through ship medical facilities
In clinical trials, people lost an average of 9.4% to 14.7% of their body weight over 40 weeks
Millions of people are now taking GLP-1 receptor agonists, primarily for weight loss, and demand has exploded worldwide
Ferroptosis and endoplasmic reticulum stress in ischemic stroke